For further details see:
Evolus cut to hold from buy at TruistFor further details see:
Evolus cut to hold from buy at TruistMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Allergan Aesthetics Celebrates the Second Annual JUVÉDERM® Day PR Newswire Join the seven million loyal Allē Members in celebrating the second annual JUVÉDERM ® Day on August 21, 2024 Members receive an exclusive gift card offer and ...
--INVOKE-2 is the first global Phas e 2 trial evaluating the safety and efficacy of a TREM2 agonist, AL002, in slowing disease progression in individuals with early Alzheimer’s disease (AD)-- --Baseline characteristics data for the INVOKE-2 study confirm a representative stud...
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire The marketing authorization for SKYRIZI ® (risankizumab) marks its fourth approved indication ...